Study cohort
CKD
KIDNEY DISEASE
During the period April 2019 to December 2021, patients with CKD who underwent a 2D-SWE examination and a renal biopsy at our institution were prospectively and consecutively included. The criteria for study enrollment were as follows: (1) a diagnosis of CKD was made in accordance with the Kidney Disease Improving Global Outcomes (KDIGO) guidelines (2012) [